104 related articles for article (PubMed ID: 7214300)
1. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
Schnuda ND
Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
[TBL] [Abstract][Full Text] [Related]
2. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
Cercek L; Cercek B; Franklin CI
Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
[TBL] [Abstract][Full Text] [Related]
3. Tumour specificity of the SCM test for cancer diagnosis.
Chaitchik S; Asher O; Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
[TBL] [Abstract][Full Text] [Related]
4. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
Balding P; Light PA; Preece AW
Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
[TBL] [Abstract][Full Text] [Related]
5. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
Orjasaeter H; Jordfald G; Svendsen I
Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the SCM test in cancer diagnosis.
Atkinson RJ; Lowry WS; Strain P
Cancer; 1983 Jul; 52(1):91-100. PubMed ID: 6342753
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test).
Pritchard JA; Sutherland WH
Br J Cancer; 1978 Aug; 38(2):339-43. PubMed ID: 698051
[No Abstract] [Full Text] [Related]
8. The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.
Mitchell H; Wood P; Pentycross CR; Abel E; Bagshawe KD
Br J Cancer; 1980 May; 41(5):772-7. PubMed ID: 6158967
[TBL] [Abstract][Full Text] [Related]
9. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
[TBL] [Abstract][Full Text] [Related]
11. Validation of the SCM-test for the diagnosis of cancer.
Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):187-93. PubMed ID: 6681765
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between patients with malignant diseases and non-malignant diseases or healthy donors by changes of fluorescence polarization in the cytoplams of circulating lymphocytes.
Hashimoto Y; Yamanaka T; Takaku F
Gan; 1978 Apr; 69(2):145-9. PubMed ID: 680459
[TBL] [Abstract][Full Text] [Related]
13. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
[TBL] [Abstract][Full Text] [Related]
14. [Studies on fluorescence polarization of human blood lymphocytes (SCM test) using a Percoll gradient centrifugal separation method].
Tenzaki T; Matsumoto J; Ishiguro T; Yoshida Y; Sugiyama S
Rinsho Byori; 1984 Apr; 32(4):394-8. PubMed ID: 6088848
[No Abstract] [Full Text] [Related]
15. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
[TBL] [Abstract][Full Text] [Related]
16. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.
Cercek L; Cercek B
Br J Cancer; 1976 May; 33(5):539-43. PubMed ID: 1276032
[TBL] [Abstract][Full Text] [Related]
17. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.
Cercek L; Cercek B
Eur J Cancer (1965); 1977 Sep; 13(9):903-15. PubMed ID: 334557
[No Abstract] [Full Text] [Related]
18. Adaptation of the cellscan technique for the SCM test in breast cancer.
Rahmani H; Deutsch M; Ron I; Gerbat S; Tirosh R; Weinreb A; Chaitchik S; Lalchuk S
Eur J Cancer; 1996 Sep; 32A(10):1758-65. PubMed ID: 8983287
[TBL] [Abstract][Full Text] [Related]
19. Simplified technique for the T-globulin cancer test.
Tal C; Raychaudhuri A; Megel H; Herberman RB; Buncher CR
J Natl Cancer Inst; 1973 Jul; 51(1):33-43. PubMed ID: 4720884
[No Abstract] [Full Text] [Related]
20. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
